+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
MOLBIO

Molbio Diagnostics Share Price

₹1,336.00 -24.2 (-1.78%)

09 Nov, 2026 3:54 PM (IST)

Molbio Diagnostics live price: ₹1,336.00. It opened at ₹1,357 vs previous close ₹1,360; intraday high/low: ₹1,371/₹1,322. The 50 DMA stands at ₹1,299.10.

Molbio Diagnostics Performance

  • Today's Low
  • ₹1,322
  • Today's High
  • ₹1,371
  • 52 Week Low
  • ₹926
  • 52 Week High
  • ₹1,687
  • Open Price₹1,357
  • Previous Close₹1,360
  • Volume178,810
  • 50 DMA₹1,299.10
  • 100 DMA-
  • 200 DMA-

Molbio Diagnostics Chart

Investment Returns

  • Over 1 Month -7.13%
  • Over 3 Month + 65.55%
  • Over 6 Month + 65.55%
  • Over 1 Year + 65.55%

Smart Investing Starts Here Start SIP with Molbio Diagnostics for Steady Growth!

Invest Now

Molbio Diagnostics Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 99.7
  • PEG Ratio
  • -
  • Market Cap Cr
  • 15,396
  • P/B Ratio
  • 13.2
  • Average True Range
  • 86.4
  • EPS
  • 13.4
  • Dividend Yield
  • 0
  • MACD Signal
  • 4.1
  • RSI
  • 49.57
  • MFI
  • 48.06

Latest Stock News Updates

Molbio Diagnostics Ltd - 544866 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Submission of Newspaper Adverstisement of Un-audited Financial Results (Standalone & Consolidated) for the quarter and half year ended September 30, 2026

Molbio Diagnostics Ltd - 544866 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

Monitoring Agency Report on the utilization of proceeds raised through issuance of equity shares by way of Public Issue of the Company

Q2FY27 Quarterly Result Announced for Molbio Diagnostics Ltd.

<h3><span style="font-size:16px;"><strong>Healthcare Services company Molbio Diagnostics announced Q2FY27 results</strong></span></h3> <p><strong>Standalone Financial Highlights:</strong><!--TgQPHd|||[[2,[null,null,1,null,null,null,null,null,null,null,null,null,[351768,null,0]],[],null,1]]--></p> <ul data-complete="true" data-hveid="CAAIDBAA" data-processed="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="wiLEJc#NS0kde" jsuid="VJYMYb_2p"> <li data-complete="true" data-hveid="CAAIDBAB" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="VJYMYb_2q">Revenue from Operations:<!--TgQPHd|||[]--> For Q2FY27<!--TgQPHd|||[]-->, standalone revenue from operations stood at Rs 2,488.79 million<!--TgQPHd|||[]-->, representing a sequential decrease of 37.68% QoQ from Rs 3,993.78 million in Q1FY27 and a YoY drop of 57.04% compared to Rs 5,793.11 million in Q2FY26. For H1FY27<!--TgQPHd|||[]-->, standalone revenue from operations reached Rs 6,482.57 million<!--TgQPHd|||[]-->, up 3.90% YoY against Rs 6,746.31 million in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIDBAB" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="VJYMYb_2q">Total Income:<!--TgQPHd|||[]--> For Q2FY27<!--TgQPHd|||[]-->, standalone total income recorded Rs 2,528.50 million<!--TgQPHd|||[]-->, demonstrating a decline of 36.90% QoQ from Rs 4,007.46 million in Q1FY27 and down 56.47% YoY from Rs 5,809.01 million in Q2FY26. For H1FY27<!--TgQPHd|||[]-->, standalone total income reached Rs 6,535.96 million<!--TgQPHd|||[]-->, showing a YoY decline of 3.56% against Rs 6,777.03 million in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIDBAB" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="VJYMYb_2q">Profit Before Tax (PBT):<!--TgQPHd|||[]--> For Q2FY27<!--TgQPHd|||[]-->, standalone PBT came in at Rs 423.53 million<!--TgQPHd|||[]-->, showcasing a drop of 44.22% QoQ from Rs 759.24 million in Q1FY27 and a decline of 65.61% YoY compared to Rs 1,231.67 million in Q2FY26. For H1FY27<!--TgQPHd|||[]-->, standalone PBT touched Rs 1,182.77 million<!--TgQPHd|||[]-->, representing a growth of 11.89% YoY from Rs 1,057.06 million in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIDBAB" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="VJYMYb_2q">Profit After Tax (PAT):<!--TgQPHd|||[]--> For Q2FY27<!--TgQPHd|||[]-->, standalone PAT stood at Rs 313.78 million<!--TgQPHd|||[]-->, indicating a drop of 44.59% QoQ from Rs 566.27 million in Q1FY27 and down 65.88% YoY against Rs 919.60 million in Q2FY26. For H1FY27<!--TgQPHd|||[]-->, standalone PAT reached Rs 880.05 million<!--TgQPHd|||[]-->, which is a YoY expansion of 12.03% compared to Rs 785.55 million in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIDBAB" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="VJYMYb_2q">Earnings Per Equity Share (EPS):<!--TgQPHd|||[]--> For Q2FY27<!--TgQPHd|||[]-->, standalone basic and diluted EPS came in at Rs 2.75<!--TgQPHd|||[]--> (dropping 45.22% QoQ from Rs 5.02 in Q1FY27 and down 66.30% YoY from Rs 8.16 in Q2FY26). For H1FY27<!--TgQPHd|||[]-->, standalone basic and diluted EPS registered at Rs 7.76<!--TgQPHd|||[]-->, growing 11.33% YoY against Rs 6.97 in H1FY26.<!--TgQPHd|||[]--></li> </ul> <p><!--TgQPHd|||[]--></p> <p><strong>Consolidated Financial Highlights:</strong><!--TgQPHd|||[[2,[null,null,1,null,null,null,null,null,null,null,null,null,[351768,null,0]],[],null,1]]--></p> <ul data-complete="true" data-hveid="CAAIDBAA" data-processed="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="wiLEJc#NS0kde" jsuid="VJYMYb_2p"> <li data-complete="true" data-hveid="CAAIDBAB" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="VJYMYb_2q">Revenue from Operations:<!--TgQPHd|||[]--> For Q2FY27<!--TgQPHd|||[]-->, consolidated revenue from operations stood at Rs 2,590.20 million<!--TgQPHd|||[]-->, sequential decrease of 36.57% QoQ compared to Rs 4,083.76 million in Q1FY27 and a drop of 55.36% YoY from Rs 5,802.67 million in Q2FY26. For H1FY27<!--TgQPHd|||[]-->, consolidated revenue from operations marked Rs 6,673.96 million<!--TgQPHd|||[]-->, a lower turn of 1.85% YoY from Rs 6,799.75 million in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIDBAB" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="VJYMYb_2q">Total Income:<!--TgQPHd|||[]--> For Q2FY27<!--TgQPHd|||[]-->, consolidated total income logged Rs 2,647.94 million<!--TgQPHd|||[]-->, shedding 35.65% QoQ from Rs 4,114.76 million in Q1FY27 and sliding 54.45% YoY from Rs 5,813.59 million in Q2FY26. For H1FY27<!--TgQPHd|||[]-->, consolidated total income came to Rs 6,762.70 million<!--TgQPHd|||[]-->, soft by 0.81% YoY compared to Rs 6,818.27 million in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIDBAB" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="VJYMYb_2q">Profit Before Tax (PBT):<!--TgQPHd|||[]--> For Q2FY27<!--TgQPHd|||[]-->, consolidated PBT reached Rs 175.05 million<!--TgQPHd|||[]-->, which is 76.94% QoQ lower than Rs 759.09 million in Q1FY27 and down 88.15% YoY against Rs 1,477.40 million in Q2FY26. For H1FY27<!--TgQPHd|||[]-->, consolidated PBT touched Rs 934.14 million<!--TgQPHd|||[]-->, illustrating a decrease of 19.79% YoY over Rs 1,164.62 million in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIDBAB" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="VJYMYb_2q">Profit After Tax (PAT):<!--TgQPHd|||[]--> For Q2FY27<!--TgQPHd|||[]-->, consolidated PAT registered at Rs 77.01 million<!--TgQPHd|||[]-->, translating to an 85.40% QoQ reduction over Rs 527.44 million in Q1FY27 and falling 92.79% YoY over Rs 1,068.43 million in Q2FY26. For H1FY27<!--TgQPHd|||[]-->, consolidated PAT finished at Rs 604.45 million<!--TgQPHd|||[]-->, down 27.09% YoY from Rs 828.99 million in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIDBAB" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="VJYMYb_2q">Earnings Per Equity Share (EPS):<!--TgQPHd|||[]--> For Q2FY27<!--TgQPHd|||[]-->, consolidated basic and diluted EPS stood at Rs 1.33<!--TgQPHd|||[]--> (down 74.47% QoQ from Rs 5.21 in Q1FY27 and down 86.34% YoY from Rs 9.74 in Q2FY26). For H1FY27<!--TgQPHd|||[]-->, consolidated basic EPS was Rs 6.52<!--TgQPHd|||[]--> (down 14.55% YoY from Rs 7.63 in H1FY26) and consolidated diluted EPS was Rs 6.51<!--TgQPHd|||[]--> (down 14.68% YoY from Rs 7.63 in H1FY26).</li> </ul> <p><a class="lb" href="/get-document/post/pdf/5935044/" target="_blank">Result PDF</a></p>

Molbio Diagnostics Financials

Molbio Diagnostics Technicals

EMA & SMA

Current Price
₹1,336.00
-24.2 (-1.78%)
pointer
  • Bearish Moving Average 9
  • Bullish Moving Average 2
  • 20 Day
  • ₹1,346.70
  • 50 Day
  • ₹1,299.10
  • 100 Day
  • -
  • 200 Day
  • -

Resistance and Support

1342.93 Pivot Speed
  • R3 1,412.10
  • R2 1,391.30
  • R1 1,363.70
  • S1 1,315.30
  • S2 1,294.50
  • S3 1,266.90

Molbio Diagnostics Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-11-05 Quarterly Results
2026-09-05 Quarterly Results

Molbio Diagnostics Shareholding Pattern

41.29%
38.04%
11.06%
8.03%
1.59%

About Molbio Diagnostics

Molbio Diagnostics are an innovative point-of-care (“POC”) diagnostics company focused on expanding access to accurate, rapid and cost-effective healthcare technologies to diagnose infectious and non-communicable diseases. View More
  • NSE Symbol
  • MOLBIO
  • BSE Symbol
  • 544866
  • ISIN
  • INE869T01028

Similar Stocks to Molbio Diagnostics

Molbio Diagnostics FAQs

Molbio Diagnostics share price is ₹1,336 As on 11 November, 2026 | 00:27

The Market Cap of Molbio Diagnostics is ₹15396.1 Cr As on 11 November, 2026 | 00:27

The P/E ratio of Molbio Diagnostics is 99.7 As on 11 November, 2026 | 00:27

The PB ratio of Molbio Diagnostics is 13.2 As on 11 November, 2026 | 00:27

The 52 week High & Low of Molbio Diagnostics is ₹1686.8/₹926.4 respectively As on 11 November, 2026 | 00:27

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23